The Medical Case for Curing All Patients with Hepatitis C
Hepatitis C in the African American Community
Hepatitis C and the Opioid Crisis
Hepatitis C and Incarceration
Health Effects of Hepatitis C Outside of the Liver
Hepatitis C Outside of the Liver: Mixed Cryoglobulinemia, Kidney Disease, and B-Cell Non-Hodgkin’s Lymphoma
Elimination of Hepatitis B and C: A National Strategy
Hepatitis C: It’s About More than Liver Disease: Fatigue, Depression, and Chronic Pain
Hepatitis C: It’s About More than Liver Disease: Diabetes and Heart Disease
Hepatitis C: It’s About More than Liver Disease: Skin Conditions Related to Hepatitis C Infection
USPSTF Universal Hepatitis C Screening Guidance
Safer Drug Use During the COVID-19 Outbreak
Syringe Services and Harm Reduction Provider Operations During the COVID-19 Outbreak
CDC Universal Hepatitis C Screening Guidelines
The Centers for Disease Control and Prevention (CDC) now recommends one-time screening for hepatitis C infection in all U.S. adults and pregnant persons during each pregnancy.
Public Communications for Hepatitis Advocacy
Public Communications for Hepatitis Advocacy Policy advocacy relies on publicly-facing communications to inform community awareness, call attention to barriers to care, and call for leaders to take action. In this educational webinar, NVHR Advocates will learn how to shape their communications to drive progress in their communities. This webinar will dive into specific methods for...
State Viral Hepatitis Advocacy
State Viral Hepatitis Advocacy This presentation co-hosted by the National Viral Hepatitis Roundtable and the Hep B Foundation will provide viral hepatitis advocates with tangible skills and strategies to get involved in state-level viral hepatitis advocacy. Presenters will address: identifying legislative calendars, working with your Governor’s office, influencing appropriations, sharing lived experiences for advocacy, and...
340B Demystified The 340B Drug Pricing Program is a valuable tool for many providers of viral hepatitis care. We hear often from clinicians and public health programs unsure about how to best utilize the program to benefit underserved populations. On this webinar we will hear from experts in the field who will provide details about...
Defining Priorities and Strategies for Viral Hepatitis
Defining Priorities and Strategies for Viral Hepatitis This is the first event of the NVHR Provider Advocacy Network. We will discuss viral hepatitis policy priorities as a group, and will learn about the various ways in which providers may consider engaging in advocacy in 2020.
Hepatitis C Vertical Transmission
Hepatitis C Vertical Transmission The U.S. is experiencing increased rates of hepatitis C infections among pregnant persons and vertical transmission to newborns. On this webinar we will explore these trends and strategies to address them. We will also hear from several NVHR Hepatitis C Patient Advocates who have lived experience with vertical transmission.
Addressing Viral Hepatitis in Rural United States
Addressing Viral Hepatitis in Rural United States Increases in injection drug use associated with the opioid crisis have driven transmission of viral hepatitis A, B, and C in rural communities in the U.S. Rural populations face unique needs which may not be met by urban models of service provision. This webinar will feature experiences from...